Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
第一作者:
C D,Murray
第一单位:
Academic Unit of Ophthalmology, York Teaching Hospital NHS Foundation Trust, York, UK.
作者:
医学主题词
乙酰唑胺(Acetazolamide);投药, 口服(Administration, Oral);老年人(Aged);老年人, 80以上(Aged, 80 and over);血管生成抑制剂(Angiogenesis Inhibitors);碳酸酐酶抑制剂(Carbonic Anhydrase Inhibitors);女(雌)性(Female);青光眼(Glaucoma);人类(Humans);眼内压(Intraocular Pressure);玻璃体内注射(Intravitreal Injections);男(雄)性(Male);高眼压(Ocular Hypertension);眼药水(Ophthalmic Solutions);眼压测量法(Tonometry, Ocular);血管内皮生长因子A(Vascular Endothelial Growth Factor A);湿性黄斑变性(Wet Macular Degeneration)
DOI
10.1038/eye.2014.180
PMID
25081290
发布时间
2021-10-21
- 浏览32
Eye (London, England)
1218-22页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



